Author:
Chen B,Zhao W-L,Jin J,Xue Y-Q,Cheng X,Chen X-T,Cui J,Chen Z-M,Cao Q,Yang G,Yao Y,Xia H-L,Tong J-H,Li J-M,Chen J,Xiong S-M,Shen Z-X,Waxman S,Chen Z,Chen S-J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference23 articles.
1. Heaney ML, Golde DW . Myelodysplasia. N Engl J Med 1999; 340: 1649–1660.
2. Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7: 1315–1323.
3. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H et al. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993; 7: 499–508.
4. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Cytogenetics of myelodysplastic syndromes. Blood 1997; 89: 2079–2088.
5. Lee JH, Shin YR, Lee JS, Kim WK, Chi HS, Park CJ et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Leukemia 2003; 17: 305–313.